trial

Critical Time Intervention-Task Shifting: Randomized Controlled Trial

NCTId NCT01995864
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 110 (actual)
Sponsored by Columbia University
Primary completion 2020-06-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
110 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2014-02
Primary completion
2020-06-01
Eligibility
ALL · 21 Years · 65 Years

Interventions & indications

Drugs
CTI-TS

Sponsors

Columbia UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

4
Ezra Susser, MD, DrPHPrincipal Investigator
Graciela Rojas, MDPrincipal Investigator
Sandro Galea, MD DrPHPrincipal Investigator
Ruben Alvarado, MD PhDPrincipal Investigator

Sites

2 total
Rio de Janeiro, BrazilSantiago, Chile

Facts & assertions

4 sourced
Enrollment
110
Phase
NA
Primary Completion Date
2020-06-01
Status
COMPLETED
relationships
The graph out of here
drug
CTI-TS
drug
lead_sponsor
Columbia University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Psychotic Disorders
indication
Schizophrenia
indication
investigator
Ezra Susser, MD, DrPH
person
Graciela Rojas, MD
person
Sandro Galea, MD DrPH
person
Ruben Alvarado, MD PhD
person